In CCK8 assays, we found that PARP1 overexpression significantly promoted, while PARP1 knockdown inhibited, the proliferation of CCA cells under hypoxic conditions (Supplementary 9D). The gene discussed is PARP1; the disease is cholangiocarcinoma.